GRM3 and schizophrenia: In addition, carriers of a risk haplotype of the metabotropic glutamate receptor 3 (GRM3) for schizophrenia had lower EAAT2 expression in the prefrontal cortex as well as impaired cognitive function in respect of verbal fluency and list learning [17].